BioXcel Therapeutics, Inc. (BTAIQ) stock
BTAIQOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 3/30
$0.03−0.00 (-13.49%)
Close on Oct 19, 2026Market cap $757.50KP/E –Yield –
BioXcel Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
BioXcel Therapeutics's enterprise value was $92.39M on Oct 19, 2026, against $104.82M a year earlier. Over the last 5 years it ranged from $43.35M to $797.78M, with a median of $111.10M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $92.39M | -12.0% |
| 2025 | Dec 31, 2025 | $104.94M | +31.3% |
| 2024 | Dec 31, 2024 | $79.93M | -16.3% |
| 2023 | Dec 29, 2023 | $95.49M | -79.3% |
| 2022 | Dec 30, 2022 | $461.32M | +46.0% |
| 2021 | Dec 31, 2021 | $315.92M | -64.6% |
| 2020 | Dec 31, 2020 | $891.77M | +299.5% |
| 2019 | Dec 31, 2019 | $223.24M | +1582.3% |
| 2018 | Dec 31, 2018 | $13.27M | – |
See a number that looks wrong?